FKBP10 and central nervous system cancer: Immunochemistry analysis showed that FKBP10 was undetectable in all the tested non-neoplastic tissues, but strongly expressed in 5.4%, 40.0% and 64.7% of grades 2, 3, 4 gliomas, with an increasing frequency in higher grade tumors (Fig. 1a, b).